Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Gomis

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Differentiation; Research in Biological Diversity|October 11, 2007
Induction of pancreatic islet cell differentiation by the neurogenin-neuroD cascadeRosa Gasa, Caroline Mrejen, Francis C Lynn, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial designThomas Strack, Luc Martinez, Stefano Del Prato, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 21, 2013
Tungstate promotes β-cell survival in Irs2-/- miceJoana Moitinho Oliveira, Sandra A Rebuffat, Rosa Gasa, et al.
Endocrinology|July 23, 2013
Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual β-cellsAlejandro Gonzalez, Beatriz Merino, Laura Marroquí, et al.
Revista Espanola De Cardiologia (English Ed.)|May 28, 2014
Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (southern Spain). Comparison with national prevalence data. The Di@bet.es studySergio Valdés, Francisca García-Torres, Cristina Maldonado-Araque, et al.
European Heart Journal|February 2, 2010
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trialMichel Komajda, John J V McMurray, Henning Beck-Nielsen, et al.
Metabolic Syndrome and Related Disorders|October 29, 2015
Early Effect of Bariatric Surgery on the Circadian Rhythms of Adipokines in Morbidly Obese WomenJosé Fabiano Costa Justus, Antonio Carlos Ligocki Campos, Ana Lucia C Figueroa, et al.
Lancet (London, England)|June 9, 2009
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trialPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
Plos One|October 3, 2013
Gastric inhibitory polypeptide receptor methylation in newly diagnosed, drug-naïve patients with type 2 diabetes: a case-control studySilvia Canivell, Elena G Ruano, Antoni Sisó-Almirall, et al.
Diabetes|March 29, 2003
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki ratsAnna Abella, Luc Marti, Marta Camps, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Differentiation; Research in Biological Diversity|October 11, 2007
Induction of pancreatic islet cell differentiation by the neurogenin-neuroD cascadeRosa Gasa, Caroline Mrejen, Francis C Lynn, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial designThomas Strack, Luc Martinez, Stefano Del Prato, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 21, 2013
Tungstate promotes β-cell survival in Irs2-/- miceJoana Moitinho Oliveira, Sandra A Rebuffat, Rosa Gasa, et al.
Endocrinology|July 23, 2013
Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual β-cellsAlejandro Gonzalez, Beatriz Merino, Laura Marroquí, et al.
Revista Espanola De Cardiologia (English Ed.)|May 28, 2014
Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (southern Spain). Comparison with national prevalence data. The Di@bet.es studySergio Valdés, Francisca García-Torres, Cristina Maldonado-Araque, et al.
European Heart Journal|February 2, 2010
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trialMichel Komajda, John J V McMurray, Henning Beck-Nielsen, et al.
Metabolic Syndrome and Related Disorders|October 29, 2015
Early Effect of Bariatric Surgery on the Circadian Rhythms of Adipokines in Morbidly Obese WomenJosé Fabiano Costa Justus, Antonio Carlos Ligocki Campos, Ana Lucia C Figueroa, et al.
Lancet (London, England)|June 9, 2009
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trialPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
Plos One|October 3, 2013
Gastric inhibitory polypeptide receptor methylation in newly diagnosed, drug-naïve patients with type 2 diabetes: a case-control studySilvia Canivell, Elena G Ruano, Antoni Sisó-Almirall, et al.
Diabetes|March 29, 2003
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki ratsAnna Abella, Luc Marti, Marta Camps, et al.
Pageof 11